The cannabis market has been notoriously successful over the course of the past few months to years, but as new legislation continues to hit the market and the public sentiment on cannabis changes, it seems as though the future of cannabis could be even more lucrative than it is today. Many companies have begun to move to the forefront of the cannabis space as the market begins to be more inclusive, and here are just a few.

The first company that should come as no surprise is the company GW Pharmaceuticals (NASDAQ:GWPH). The company is a U.K. based biotech company based in the cannabis space. GW produced the drug known as Epidiolex which is a pharmaceutical medicine made from one of the components of the cannabis plant. According to one report “ Epidiolex, became the first cannabis-based FDA-approved drug. The drug will treat epilepsy, and more specifically people who suffer from Dravet and Lennox-Gastaut Syndrome. This news is important for several reasons and is another huge step toward legalization of medical marijuana at the federal level.” Drugs in the pharmaceutical side of cannabis have been shown to have a large amount of potential for help within the patient as well as growth in the stock. For these reasons, only time and legislation will tell how well GWPH can continue to do in the market.

The company Zynerba Pharmaceuticals (NASDAQ:ZYNE) is another one of the big players in the pharmaceutical side of the cannabis space. The company has been working to research how various parts of the cannabis plant affect various diseases and ailments. The company has been working to find a treatment for Tourette’s syndrome using the cannabis plant.

Another company in the cannabis space that has managed to stay at the forefront of the industry is the company Leafbuyer Technologies Inc. ( LBUY ). The company is an online resource for those in the cannabis space and has been hailed as one of the best at its trade. The company has also recently reported a large increase in their online traffic which means that they should remain on any investors watch list for the near future. The website provides a large amount of information for distributors and for individual consumers who want to learn about the product they are buying and where to purchase it.

The cannabis industry has remained one of the most lucrative ways to invest for the past several months and as the changing tide of legislation and the public perception changes, it only looks as though this will increase into the near future.

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 NOW EXTENDED TO 10/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 ( CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like